北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 呼吸内科  > 期刊论文
学科主题: 临床医学
题名:
Interleukin-32, not reduced by salmeterol/fluticasone propionate in smokers with chronic obstructive pulmonary disease
作者: Du Yipeng; Wang Wei; Yang Wei; He Bei
关键词: interleukins ; pulmonary disease ; chronic obstructive ; anti-inflammatory agents, interleukin 32 protein ; human
刊名: CHINESE MEDICAL JOURNAL
发表日期: 2014-05-05
DOI: 10.3760/cma.j.issn.0366-6999.20132625
卷: 127, 期:9, 页:1613-1618
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal
研究领域[WOS]: General & Internal Medicine
关键词[WOS]: AIRWAY INFLAMMATION ; KAPPA-B ; COPD ; CYTOKINE ; IL-32 ; SPUTUM ; ASSOCIATION ; EMPHYSEMA ; ASTHMA
英文摘要:

Background The interleukin (IL)-32/tumor necrosis factor (TNF) alpha pathway is supposed to play a key role in the amplification of the immune response in chronic obstructive pulmonary disease (COPD) inflammation. Inhaled corticosteroids (ICS) in combination with long-acting beta 2-agonists (LABA) have shown airway anti-inflammatory effects in recent studies, but the mechanism is still uncertain.

Methods Patients were treated in a randomized, open-labeled, parallel group clinical trial with either a combination of salmeterol xinafoate/fluticasone propionate (SF; Seretide, GlaxoSmithKline) Diskus (50/500 mu g twice daily) or ipratropium bromide/salbutamol (IS; Combivent, Boehringer Ingelheim) MDI (42 mu g/240 mu g quartic daily) for 12 weeks. At the start and the end of treatment, induced sputum was collected and the concentration of IL-32 and TNF-alpha, the number of neutrophils and eosinophils were measured.

Results Following 12 weeks of treatment, a statistically significant fall from baseline in the concentration of TNF-alpha in sputum (P=0.004) was seen after treatment with SF but not with IS. However, neither treatment had significant effects on the concentration of IL-32 in sputum. There was a decrease from baseline in the number of sputum neutrophils with SF that approached statistical significance (P=0.028) but not with IS, while the number of sputum eosinophils did not change significantly from baseline in either treatment group. There was a statistically significant decline from baseline in the quality of life as assessed by the St George′s respiratory questionnaire in both the SF (P=0.004) and IS (P=0.030) treatment groups, but no evidence of improvement in lung function was observed in either group.

Conclusion The sputum TNF-alpha and neutrophils, but not IL-32 and macrophages, could be reduced by ICS/LABA treatment, suggesting that IL-32 could be involved in the corticosteroid resistance of COPD inflammation.

语种: 英语
所属项目编号: 30770939
项目资助者: National Natural Science Foundation of China
WOS记录号: WOS:000335936800003
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/60395
Appears in Collections:北京大学第三临床医学院_呼吸内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Hosp 3, Dept Resp Med, Beijing 100191, Peoples R China

Recommended Citation:
Du Yipeng,Wang Wei,Yang Wei,et al. Interleukin-32, not reduced by salmeterol/fluticasone propionate in smokers with chronic obstructive pulmonary disease[J]. CHINESE MEDICAL JOURNAL,2014,127(9):1613-1618.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Du Yipeng]'s Articles
[Wang Wei]'s Articles
[Yang Wei]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Du Yipeng]‘s Articles
[Wang Wei]‘s Articles
[Yang Wei]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace